These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20199197)

  • 1. Unexplained fetal death is associated with increased concentrations of anti-angiogenic factors in amniotic fluid.
    Chaiworapongsa T; Romero R; Kusanovic JP; Savasan ZA; Kim SK; Mazaki-Tovi S; Vaisbuch E; Ogge G; Madan I; Dong Z; Yeo L; Mittal P; Hassan SS
    J Matern Fetal Neonatal Med; 2010 Aug; 23(8):794-805. PubMed ID: 20199197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal death: a condition with a dissociation in the concentrations of soluble vascular endothelial growth factor receptor-2 between the maternal and fetal compartments.
    Chaiworapongsa T; Kusanovic JP; Savasan ZA; Mazaki-Tovi S; Kim SK; Vaisbuch E; Tarca AL; Mittal P; Ogge G; Madan I; Dong Z; Yeo L; Hassan SS; Romero R
    J Matern Fetal Neonatal Med; 2010 Sep; 23(9):960-72. PubMed ID: 20158395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study.
    Romero R; Chaiworapongsa T; Erez O; Tarca AL; Gervasi MT; Kusanovic JP; Mittal P; Ogge G; Vaisbuch E; Mazaki-Tovi S; Dong Z; Kim SK; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2010 Dec; 23(12):1384-99. PubMed ID: 20459337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes.
    Savasan ZA; Romero R; Chaiworapongsa T; Kusanovic JP; Kim SK; Mazaki-Tovi S; Vaisbuch E; Mittal P; Ogge G; Madan I; Dong Z; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2010 Aug; 23(8):828-41. PubMed ID: 20158393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.
    Chaiworapongsa T; Romero R; Savasan ZA; Kusanovic JP; Ogge G; Soto E; Dong Z; Tarca A; Gaurav B; Hassan SS
    J Matern Fetal Neonatal Med; 2011 Oct; 24(10):1187-207. PubMed ID: 21827221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
    Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexplained fetal death: another anti-angiogenic state.
    Espinoza J; Chaiworapongsa T; Romero R; Kim YM; Kim GJ; Nien JK; Kusanovic JP; Erez O; Bujold E; Gonçalves LF; Gomez R; Edwin S
    J Matern Fetal Neonatal Med; 2007 Jul; 20(7):495-507. PubMed ID: 17674262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoglin in amniotic fluid as a risk factor for the subsequent development of bronchopulmonary dysplasia.
    Kim SK; Romero R; Savasan ZA; Xu Y; Dong Z; Lee DC; Yeo L; Hassan SS; Chaiworapongsa T
    Am J Reprod Immunol; 2013 Feb; 69(2):105-23. PubMed ID: 23279628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.
    Soto E; Romero R; Kusanovic JP; Ogge G; Hussein Y; Yeo L; Hassan SS; Kim CJ; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2012 May; 25(5):498-507. PubMed ID: 21867402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
    Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.
    Chaiworapongsa T; Romero R; Korzeniewski SJ; Cortez JM; Pappas A; Tarca AL; Chaemsaithong P; Dong Z; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2014 Jan; 27(2):132-44. PubMed ID: 23687930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute pyelonephritis during pregnancy changes the balance of angiogenic and anti-angiogenic factors in maternal plasma.
    Chaiworapongsa T; Romero R; Gotsch F; Kusanovic JP; Mittal P; Kim SK; Erez O; Vaisbuch E; Mazaki-Tovi S; Kim CJ; Dong Z; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2010 Feb; 23(2):167-78. PubMed ID: 20213923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice.
    Oggè G; Romero R; Kusanovic JP; Chaiworapongsa T; Dong Z; Mittal P; Vaisbuch E; Mazaki-Tovi S; Gonzalez JM; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2010 Aug; 23(8):820-7. PubMed ID: 20158394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study.
    Chaiworapongsa T; Romero R; Tarca A; Kusanovic JP; Mittal P; Kim SK; Gotsch F; Erez O; Vaisbuch E; Mazaki-Tovi S; Pacora P; Ogge G; Dong Z; Kim CJ; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2009 Dec; 22(12):1122-39. PubMed ID: 19916710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.
    Adekola H; Romero R; Chaemsaithong P; Korzeniewski SJ; Dong Z; Yeo L; Hassan SS; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2015; 28(14):1621-32. PubMed ID: 25211383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early anti-angiogenic proteins expression in amniotic fluid of twin fetuses.
    Wang CN; Chen JY; Chao AS; Cheng PJ; Chang SD; Wang TH
    Twin Res Hum Genet; 2011 Oct; 14(5):452-6. PubMed ID: 21962138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation.
    Chaiworapongsa T; Espinoza J; Gotsch F; Kim YM; Kim GJ; Goncalves LF; Edwin S; Kusanovic JP; Erez O; Than NG; Hassan SS; Romero R
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):25-40. PubMed ID: 18175242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating angiogenic factors in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome and selective intrauterine growth restriction.
    Yinon Y; Ben Meir E; Berezowsky A; Weisz B; Schiff E; Mazaki-Tovi S; Lipitz S
    Am J Obstet Gynecol; 2014 Feb; 210(2):141.e1-7. PubMed ID: 24055584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death.
    Whitten AE; Romero R; Korzeniewski SJ; Tarca AL; Schwartz AG; Yeo L; Dong Z; Hassan SS; Chaiworapongsa T
    Am J Obstet Gynecol; 2013 Apr; 208(4):310.e1-310.e11. PubMed ID: 23333548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating angiogenic and antiangiogenic factors in women with eclampsia.
    Vaisbuch E; Whitty JE; Hassan SS; Romero R; Kusanovic JP; Cotton DB; Sorokin Y; Karumanchi SA
    Am J Obstet Gynecol; 2011 Feb; 204(2):152.e1-9. PubMed ID: 21062661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.